Cargando…
Current strategies to minimize the bleeding risk of warfarin
For many decades, the vitamin K antagonist warfarin has been the mainstay of treatment for various conditions that require anticoagulation, including atrial fibrillation. Although the efficacy of warfarin in both prevention and treatment of thrombosis has been demonstrated in numerous randomized cli...
Autores principales: | Snipelisky, David, Kusumoto, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760283/ https://www.ncbi.nlm.nih.gov/pubmed/24019755 http://dx.doi.org/10.2147/JBM.S41404 |
Ejemplares similares
-
Warfarin: Bleeding: case report
Publicado: (2021) -
Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
por: Uygungül, Evren, et al.
Publicado: (2014) -
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
por: Sherid, Muhammed, et al.
Publicado: (2016) -
Does acupuncture increase the risk of bleeding in patients taking warfarin?
por: Leem, Jungtae
Publicado: (2015) -
Triple therapy after PCI – Warfarin treatment quality and bleeding risk
por: Wadell, Daniel, et al.
Publicado: (2018)